PPP compute: Pandemic pharmacology platform for model-driven therapy optimization
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.07101E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20242026Known Financial Commitments (USD)
$0Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
dr. JGC van HasseltResearch Location
NetherlandsLead Research Institution
Universiteit LeidenResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
During a pandemic, a rapid evaluation of possible medicines to be able to treat infected patients is necessary. During the COVID-19 Pandemie, pre-clinical studies were conducted worldwide to identify possible medicines with activity against SARS-COV-2. In many cases, no clinical effect has been found for a large number of medicines. The cause for this may be in a lack of translation of experimental findings into people and/or by testing unsuitable doses.